Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FJUZM
- Awardee
-
Dakota Drug, Inc. UEI H544BCGUKW64
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,171
Award facts
- Contract value 100% obligated
- $10,170.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Anoka, MN, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,170.62 to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Enbrel 50 mg/ml SureClick medication. The delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under a firm fixed-price contract structure with no set-aside designation. This award is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, a $999,999,999.00 master contract that extends through December 31, 2025 and authorizes the company to supply a comprehensive range of pharmaceutical products and medical equipment to support U.S. Armed Forces medical operations.
Dakota Drug, Inc. has established itself as a critical supplier within the federal medical procurement marketplace, with a track record of delivering diverse pharmaceutical products including diabetes management medications, respiratory treatments, pain management drugs, cardiovascular medications, and vaccines to military healthcare facilities. The company's role as a key vendor under the DLA Troop Support Medical program demonstrates its strategic importance in maintaining medical supply chains for defense operations. This delivery order for Enbrel, a biologic immunosuppressant medication, reflects the company's continued responsibility for providing specialized pharmaceutical products essential to military medical readiness.
Quick answers
Who was awarded contract SPE2DB25FJUZM?
SPE2DB25FJUZM was awarded to Dakota Drug, Inc. by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FJUZM worth?
The government has obligated $10,171 on SPE2DB25FJUZM.
Is contract SPE2DB25FJUZM an order under another contract?
Yes. SPE2DB25FJUZM is a delivery order under SPE2DB24D8003, an indefinite delivery contract.
Was contract SPE2DB25FJUZM competed?
The extent of competition for SPE2DB25FJUZM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award